3D bioprinting of oligo(poly[ethylene glycol] fumarate) for bone and nerve tissue engineering.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32418273.
- Also identified by DOI 10.1002/jbm.a.37002 and PMC identifier 8942303.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
3D bioprinting is a promising new tissue restoration technique that enables the precise deposition of cells and growth factors in order to more closely mimic the structure and function of native organs. In this study, we report the development of a new bioink using oligo(poly[ethylene glycol] fumarate) (OPF), a photo-crosslinkable, and biodegradable polymer, for 3D bioprinting. In addition to OPF, a small portion of gelatin was also incorporated into the bioink to make it bio-printable. After immersion in the cell medium, gelatin was eluted away to create a bioprinted scaffold of pure OPF. Excellent cell viability, spreading, and long-term proliferation of encapsulated cells was observed using both bone and nerve cells as examples. These results demonstrate that OPF bioink has great potential in future 3D bioprinting applications that aim to replicate complex, layered tissues, and/or organs.
Medical subject headings
- Bone Regeneration
- Fumarates
- Nerve Regeneration
- Polyethylene Glycols
- Printing, Three-Dimensional
- Tissue Engineering